Trasylol Pulled from Market Because of Links to Higher Mortality Rate and Other Serious Side Effects
Multiple studies offer compelling evidence that the clotting drug Trasylol poses serious danger of adverse side effects, including an increased risk of death. These studies have resulted in a slew of defective drug lawsuits filed by those who suffered serious side effects after taking Trasylol, as well as a FDA initiated halt to sales of the drug.
Trasylol is a blood clotting drug used during heart surgery to prevent bleeding. Trasylol drug injections have been linked to serious adverse side effects including kidney failure, deadly heart problems and brain disease.
Trasylol (Aprotinin) is an injectable blood clotting drug manufactured by Bayer Pharmaceuticals Corporation which was approved by the FDA in December 1993 to reduce bleeding in patients who undergo heart surgery.
Trasylol reduces the level of certain enzymes that may cause increased bleeding during surgery. The drug was widely used with patients undergoing heart bypass surgery to control blood loss, but also was used in other surgeries including hip replacement surgery.
The first of the studies conducted by Duke University Medical Center revealed that 6.4 percent of patients who were given Trasylol died within 30 days of the surgery, a rate nearly 2.5 times higher than patients who were treated with another drug or who received no treatment. A subsequent study actually financed by Bayer found that the risk of death was 64 percent higher in-patients given Trasylol than in those taking a comparison drug. These initial studies resulted in the FDA limiting the use of Trasylol and strengthened its warnings in 2006.
Two subsequent studies have found similar links between Trasylol and an increased risk of death following heart bypass surgery, including a Canadian study that was halted because of concerns over the preliminary results. Although the sales of the drug was suspended in November 2007 at the request of the FDA, Bayer sold the drug for several years after early studies indicating serious side effects, which may have resulted in an estimated 22,000 additional fatalities because of the delay in pulling the drug from the market.
If you or someone you love received Trasylol related to a surgical procedure including heart bypass surgery and have developed serious side effects including kidney failure, heart problems or brain disease, you may be entitled to legal compensation. Montlick and Associates, Attorneys at Law, represents clients throughout Georgia who have suffered serious adverse side effects from defective drugs like Trasylol. OurGeorgia Trasylol injury claim attorneys are available to assist clients throughout all of Georgia and the Southeast, including but not limited to Albany, Athens, Atlanta, Augusta, Columbus, Gainesville, Macon, Marietta, Rome, Roswell, Savannah, Smyrna, Valdosta, Warner Robins and all smaller cities and rural areas in the state. No matter where you are located we are just a phone call away, and we will even come to you. Call us 24 hours a day/7 days a week for your Free Consultation at 1-800-LAW-NEED (1-800-529-6333). You can also visit us online at www.montlick.com and use our Free Case Evaluation Form or 24-hour Live Online Chat.